BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20419455)

  • 1. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy.
    Bulut D; Scheeler M; Wichmann T; Börgel J; Miebach T; Mügge A
    Clin Res Cardiol; 2010 Oct; 99(10):633-8. PubMed ID: 20419455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.
    Bulut D; Scheeler M; Niedballa LM; Miebach T; Mügge A
    Clin Res Cardiol; 2011 Jul; 100(7):603-10. PubMed ID: 21298435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.
    Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB
    Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
    Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
    J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
    Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
    Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
    Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
    J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
    Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB
    Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy.
    Bironaite D; Daunoravicius D; Bogomolovas J; Cibiras S; Vitkus D; Zurauskas E; Zasytyte I; Rucinskas K; Labeit S; Venalis A; Grabauskiene V
    BMC Cardiovasc Disord; 2015 Mar; 15():26. PubMed ID: 25888309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
    Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K
    J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
    J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
    Mobini R; Staudt A; Felix SB; Baumann G; Wallukat G; Deinum J; Svensson H; Hjalmarson A; Fu M
    J Autoimmun; 2003 Jun; 20(4):345-50. PubMed ID: 12791320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.